- Home
- BXC vs PACB Comparison
BXC vs PACB Comparison
Compare BXC & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BXC | PACB |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | 1700 | N/A |
| Industry | Wholesale Distributors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.2M | 486.1M |
| IPO Year | 2004 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BXC | PACB |
|---|---|---|
| Price | $64.38 | $1.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $86.00 | $2.20 |
| AVG Volume (30 Days) | 66.7K | ★ 6.2M |
| Earning Date | 05-27-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $4.50 | $12.46 |
| Revenue Next Year | $6.87 | $12.10 |
| P/E Ratio | $3,182.50 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $52.71 | $0.85 |
| 52 Week High | $88.30 | $2.73 |
Technical Indicators
Market Signals| Indicator | BXC | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 36.25 | 40.94 |
| Support Level | $59.47 | $1.44 |
| Resistance Level | $66.64 | $1.70 |
| Average True Range (ATR) | 3.92 | 0.14 |
| MACD | -1.34 | 0.00 |
| Stochastic Oscillator | 14.43 | 21.57 |
Price Performance
Historical ComparisonAbout BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.